CFD
UTHR icon

Creative Financial Designs’s United Therapeutics UTHR Stock Holding History

Creative Financial Designs’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08K Hold
2
– – ﹤0.01% 2012
2026
Q1 		$1.19K Buy
+2
New +$996 ﹤0.01% 1863
2019
Q1 		– Sell
-33
Closed -$4K – 653
2018
Q4 		$4K Sell
33
-34
-51% -$3.94K ﹤0.01% 463
2018
Q3 		$9K Sell
67
-81
-55% -$10K 0.01% 453
2018
Q2 		$17K Buy
+148
New +$16.3K 0.01% 386

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Creative Financial Designs's UTHR Position: Q2 2026 in Review

Creative Financial Designs held its United Therapeutics (UTHR) position steady in Q2 2026 at 2 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #2012.

Creative Financial Designs first reported a position in UTHR in Q2 2018 and has held it in 5 quarters since. The position peaked at $17K in Q2 2018. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Creative Financial Designs held 2 shares of United Therapeutics worth $1.08K as of Q2 2026.
  • Creative Financial Designs left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #2012 holding.
  • Creative Financial Designs first reported a position in United Therapeutics in Q2 2018 and has held it in 5 quarters since.
  • Creative Financial Designs's United Therapeutics position peaked at $17K in Q2 2018.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.